Curio Wellness, entered into partnership with VMO-Ops, Inc. (Village). Through the partnership, the Curio team will bring their industry expertise, operational model, and cGMP-certified products to Missouri and its over 200,000 patients statewide.
“We are excited and eager to bring our award-winning suite of products, LEAN processes, and patient-centered approach to Missouri patients,” stated Michael Bronfein, CEO of Curio Wellness. “Our discipline, unwavering focus on quality, and seasoned leadership team have enabled us to be the market leader in Maryland for five years running, and we hope to achieve similar success with Village in this new market.”
The official partnership agreement between Curio Wellness and Village allows Curio to expand its cultivation and processing businesses providing targeted therapeutics and cGMP-certified medical cannabis products throughout Missouri, beginning in 2023. Curio’s experience as a trusted licensing partner has enabled the team to also secure an agreement with Village, and licensed brands like Viola, to produce their suite of products. Initial distribution of these products will begin through Village’s two Missouri dispensaries located in St. Louis, with broader distribution to follow.
“Choosing Curio as a partner not only aligns with Village’s mission and values—including the importance of representation within the industry—but it also significantly accelerates our ability to bring high-quality medicine to patients throughout the state,” stated Dan Pettigrew, Village CEO and co-founder of both Village and Viola. “We’re thrilled to work with Curio. They bring a depth of knowledge and strategy allowing us to further optimize the operationalizing of licenses while creating meaningful careers for Missourians, with a focus on improving the lives of those in local, disadvantaged communities.”
Photo: Courtesy of Business Wire
Related News
Curio Wellness Launches Two Cannabis Product Lines Focused On Gut Health And Active Lifestyles
The Parent Company To Enter Maryland Cannabis Market Via Exclusive Partnership With Curio Wellness
This New Cannabis Patient-Focused Branded App Will Help You Track & Customize Relief
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.